Skip to main content
Table of Contents
Print

How Does Cannabis Impact Inflammation Markers in CRPS? 

Author: Dr. Clarissa Morton, PharmD

Understanding the link between cannabis and inflammation is a critical part of exploring treatment options for Complex Regional Pain Syndrome (CRPS). This condition is often marked by chronic pain, swelling, and immune dysfunction, all of which are tied closely to inflammatory responses in the body. 

Current research into cannabis and inflammation suggests that cannabinoids, especially CBD, may influence inflammatory pathways by interacting with the body’s endocannabinoid system. This interaction appears to regulate immune responses and reduce the release of pro-inflammatory cytokines, chemicals that can worsen CRPS symptoms. 

What Research Tells Us About Cannabis and the Immune System 

Although large-scale trials remain limited, several scientific methods are helping researchers learn how cannabis might reduce inflammation in CRPS patients: 

  • Scientific review 
    A growing number of reviews have evaluated preclinical and early-stage clinical studies on cannabis’s effects on inflammation. These reports highlight consistent therapeutic effects of cannabinoids in pain and autoimmune-related conditions. 
  • Experimental models 
    Animal-based experimental models of CRPS have shown reductions in inflammation and pain sensitivity when treated with cannabinoids. These models help scientists isolate how specific compounds like THC and CBD act on inflamed nerve tissue. 

While results are promising, more human trials are needed to translate these findings into safe, effective therapies for CRPS. As evidence grows, cannabis may play a larger role in managing this condition beyond symptom relief alone. 

Medical cannabis isn’t a one-size-fits-all solution, but it offers a pathway worth exploring, especially for patients navigating long-term inflammation and discomfort. 

Providers like LeafEase offer support and consultations tailored to individuals considering cannabis-based treatment for CRPS. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories